Τα καλύτερα Nephrology podcast (2025)

1
Comparative Effectiveness of Lubiprostone and Stool Softeners in CKD 3:53

10d ago3:53

3:53

In this podcast, Dr. Sumida summarizes the main findings from his study on "Comparative Effectiveness of Lubiprostone and Stool Softeners on Risk of Kidney Outcomes in Patients with CKD" on behalf of his coauthors.Από τον American Society of Nephrology

1
Episode 28: APOL1 Screening and Early Detection - Patient and Clinician Perspectives 13:30

11d ago13:30

13:30

In the final episode of KDIGO’s three-part Conversations in Nephrology series on APOL1 kidney disease, host Kirk Campbell, MD (University of Pennsylvania, United States), speaks with Titilayo Ilori, MD (Boston University, United States), and kidney health advocate Joshua Albright (United States) about how APOL1 genetic testing can shape the future …

1
Episode 27: Management of Patients with APOL1 Kidney Disease 19:15

11d ago19:15

19:15

In this second installment of KDIGO’s three-part podcast series on APOL1 kidney disease, host Kirk Campbell, MD (University of Pennsylvania, United States), welcomes Barry Freedman, MD (Wake Forest University School of Medicine, United States) for a practical discussion on patient management. They examine how APOL1 risk variants influence progressi…

1
Episode 26: Burden and Pathophysiology of APOL1 Kidney Disease 13:00

11d ago13:00

13:00

This is the first episode of a three-part KDIGO Conversations in Nephrology series on APOL1 kidney disease. Host Kirk Campbell, MD (University of Pennsylvania, United States), speaks with Bessie Young, MD (University of Washington, United States) about the discovery, burden, and biology of APOL1 kidney disease. Their discussion explores how APOL1 v…

1
Episode 25: Treatment Revolution in Iga Nephropathy 14:30

1M ago14:30

14:30

Join Dana Rizk, MD (University of Alabama at Birmingham, USA), and Shikha Wadhwani, MD (Indiana University School of Medicine, USA), for a conversation on the treatment revolution in IgAN. They discuss how breakthroughs in understanding disease pathophysiology are fueling a wave of new therapies that go beyond traditional supportive care. Key topic…

1
Episode 24: Overview of the Latest Guidance in IgA Nephropathy Management 19:00

1M ago19:00

19:00

Join Dana Rizk, MD (University of Alabama at Birmingham, United States), and Brad Rovin, MD (Ohio State University, United States), Co-Chair of the 2025 KDIGO IgAN/IgAV Guideline, for a deep dive into the latest updates in patient care. Their conversation explores the most important takeaways from the new guideline, the critical role of kidney biop…

1
SGLT2 Inhibition and Hospitalizations in Patients with Chronic Kidney Disease 3:47

1M ago3:47

3:47

In this podcast, Dr. Neuen summarizes the main findings from his study on "SGLT2 inhibition and hospitalizations in patients with CKD: Data from CREDENCE and a meta-analysis of CKD progression trials" on behalf of his colleagues.Από τον American Society of Nephrology

1
Episode 23: A Patient and Caregiver Perspective 12:15

2M ago12:15

12:15

What does life with a rare kidney disease really look like? Marianne Silkjaer Nielsen (Founder of CompCure, Denmark) offers a powerful voice for patients and caregivers. She reflects on the long diagnostic journey, the challenges of managing rare kidney disease, and the need for better awareness, advocacy, and international registries to improve ou…

1
Episode 22: Advancing Research and Novel Therapies for C3G 23:15

2M ago23:15

23:15

What does the future of treatment for C3 Glomerulopathy (C3G) look like? Dr. Nicole van de Kar (Radboud University Medical Center, The Netherlands) unpacks the pathophysiology of C3G, from genetic and autoantibody factors to the central role of the alternative pathway. She explores the limits of current C5 therapies and the potential of new strateg…

1
Episode 21: Diagnosis and Management of C3G 15:45

2M ago15:45

15:45

How do patients with C3 Glomerulopathy (C3G) present, and why is confirming the diagnosis so complex? Dr. David Kavanagh (National Renal Complement Therapeutics Centre, United Kingdom) walks through the diagnostic process, the shortcomings of traditional immunosuppression, and the promise of emerging therapies like alternative pathway inhibitors. H…

1
Episode 20: The Role of Complement in Kidney Diseases 19:45

2M ago19:45

19:45

Why does it matter if a kidney disease is complement-driven or complement-associated? Dr. Matthew Pickering (Imperial College London, United Kingdom) explains this critical distinction and why it changes how clinicians approach diagnosis and treatment. The discussion explores promising new therapies such as C3 and C5 inhibitors and how biomarkers a…

1
Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative Glomerulonephritis 3:09

2M ago3:09

3:09

In this podcast, Dr. Ghaddar summarizes the main findings from her study on "Clinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative Glomerulonephritis" on behalf of her colleagues.Από τον American Society of Nephrology

1
Perceptions of Future Earnings Among Nephrology Fellows 3:03

4M ago3:03

3:03

In this podcast, Drs. Raslan and Triozzi summarize the main findings from their study on "Assessing Current Nephrology Fellows' Perceptions of Future Earnings as Attending Physicians" on behalf of their colleagues.Από τον American Society of Nephrology

1
SGLT2 Inhibitors and Risk of Urinary Tract Infections with Abnormal Genitourinary Pathology 7:23

4M ago7:23

7:23

In this podcast, Drs. Eadon, Zhang, and Xu summarize the main findings from their study on "Risk of Urinary Tract Infections with SGLT2 Inhibitors in Subpopulations with Abnormal Genitourinary Pathology" on behalf of their colleagues.Από τον American Society of Nephrology

1
Transition Practices in Pediatric and Adult Nephrology 3:41

7M ago3:41

3:41

In this podcast, Dr. Vissing summarizes the main findings from his study on "Bridging the Gap: Assessing Nephrology Transition Practices in Pediatric and Adult Medical Centers" on behalf of his colleagues.Από τον American Society of Nephrology

1
Creatinine and Cystatin-Based Equations in People with Cancer 5:18

8M ago5:18

5:18

In this podcast, Dr. Titan summarizes the main findings from her study on "Performance of creatinine and cystatin-based equations on estimating measured GFR in people with hematological and solid cancers" on behalf of her colleagues.Από τον American Society of Nephrology

1
GLP1 Receptor Agonists and Kidney Outcomes 5:01

9M ago5:01

5:01

In this podcast, Dr. Mendonça summarizes the main findings from his study on "The Impact of Glucagon-like Peptide-1 Receptor Agonists on Kidney Outcomes: A Meta-Analysis of Randomized Placebo-Controlled Trials" on behalf of his colleagues.Από τον American Society of Nephrology

1
Anticoagulation and Fracture Risk in CKD Patients with Atrial Fibrillation 4:01

10M ago4:01

4:01

In this podcast, Drs. Khan and Paik summarize the main findings from their study on "Fracture in association with anticoagulant therapy in patients with chronic kidney disease and atrial fibrillation" on behalf of their colleagues.Από τον American Society of Nephrology

1
Comparing USRDS vs. National Death Index on Sudden Cardiac Death in Dialysis Patients 5:17

11M ago5:17

5:17

In this podcast, Dr. Shafi and Dr. Obi summarize the main findings from their study on "Comparing USRDS and National Death Index Data on Sudden Cardiac Death in US Dialysis Patients" on behalf of their colleagues.Από τον American Society of Nephrology

1
Association of Kidney Function with SGLT2 Inhibitor Discontinuation 4:05

12M ago4:05

4:05

In this podcast, Dr. Estrella summarizes the main findings from her study on "Association of kidney function with SGLT2 inhibitor discontinuation among United States Veterans" on behalf of her colleagues.Από τον American Society of Nephrology

1
Interview with 2024 CJASN Trainee of the Year – Second Place Awardee: Dr. Mohammad Azfar Qureshi 7:32

12M ago7:32

7:32

In this podcast, CJASN Editor-in-Chief Dr. Rhee interviewed Dr. Qureshi on the findings of his study "The Association of Intra-abdominal Adhesions with Peritoneal Dialysis Catheter-Related Complications."Από τον American Society of Nephrology

1
Interview with 2024 CJASN Trainee of the Year – First Place Awardee: Dr. Christine Limonte 5:53

12M ago5:53

5:53

In this podcast, CJASN Editor-in-Chief Dr. Rhee interviewed Dr. Limonte on the findings of her study "Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes."Από τον American Society of Nephrology

1
Providers' Experiences Discussing Alternatives to Kidney Replacement Therapy with Patients 5:25

1y ago5:25

5:25

In this podcast, Drs. Wong and Chotivatanapong summarize the main findings from their study on "Nephrology Providers' Experiences Discussing Care for Patients with Kidney Failure who Forgo Kidney Replacement Therapy: National Qualitative Study"Από τον American Society of Nephrology

1
Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management 17:49

1y ago17:49

17:49

CJASN editors highlight three articles centered on the theme of CKD, including articles on SGLT2 inhibitors in CKD patients; SGLT2 inhibitors and cardiovascular death in CKD; and smartphone intervention for lifestyle and hypertension management in CKD.Από τον American Society of Nephrology

1
Fellows' Perspectives on Parental Leave Policies and Family Planning 5:52

1y ago5:52

5:52

In this podcast, Dr. Kendrick and Dr. Dixon summarize the main findings from their study on "A National Survey of Pregnancy and Parenthood Among Nephrology Trainees: A Focus on Nephrology Fellowship" on behalf of their colleagues.Από τον American Society of Nephrology

1
Editors' Choice Articles: Pediatric ESKD iron stores, Impact of hemodiafiltration and hemodialysis on β-2-microglobulin, and Novel instruments for dialysis modality awareness 18:11

1+ y ago18:11

18:11

Drs. Rhee, Roshanravan, and Nigwekar highlight three cutting-edge dialysis articles on pediatric ESKD iron store biomarkers; HDF, HD, and β-2-microglobulin kinetics; and development of a novel kidney replacement therapy awareness instrument.Από τον American Society of Nephrology

1
Episode 19: Extracorporeal Blood Purification in the Context of Multiorgan Support: Current Role and Best Practices 11:00

1+ y ago11:00

11:00

Episode 19 is the third episode in KDIGO's three-episode series on acute kidney injury (AKI), hosted by Dr. Kathleen Liu (University of California at San Francisco, United States). In this episode, Dr. Liu and Dr. Claudio Ronco (International Renal Research Institute of San Bortolo Hospital, Italy) discuss recent advancements and best practices sur…

1
Episode 18: Personalized Care for AKI – The Role of Digital Decision Support Tools and Augmented Human Intelligence to Improve Outcomes in AKI 11:30

1+ y ago11:30

11:30

Episode 18 is the second episode in KDIGO's three-episode series on acute kidney injury (AKI), hosted by Dr. Kathleen Liu (University of California at San Francisco, United States). In this episode, Dr. Liu is joined by Dr. Kianoush Kashani (Mayo Clinic, United States) to discuss the rising importance of personalized care in AKI treatment. They del…

1
Episode 17: Stratifying the Risk of Persistent AKI and Clinical Practice 10:00

1+ y ago10:00

10:00

This is the first episode in KDIGO's new 3-episode series on acute kidney injury (AKI), hosted by Dr. Kathleen Liu (University of California at San Francisco, United States). In this episode, Dr. Liu is joined by Dr. Jay Koyner (University of Chicago, United States) to discuss the emerging field of persistent acute kidney injury (AKI). They delve i…

1
Kidney Measures and Venous Thromboembolism 18:10

2y ago18:10

18:10

Dr. Zhong Zheng provides an overview of his study, "Association of Estimated Glomerular Filtration Rate and Albuminuria with Venous Thromboembolism," on behalf of his colleagues.Από τον American Society of Nephrology

1
Participant Experience in the KPMP - Spanish Language 5:50

2y ago5:50

5:50

Drs. Angela Maria Victoria-Castro and Celia Pamela Corona-Villalobos summarize the findings from their study, "Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project," in Spanish.Από τον American Society of Nephrology

1
Participant Experience in the KPMP 5:01

2y ago5:01

5:01

Drs. Angela Maria Victoria-Castro and Celia Pamela Corona-Villalobos summarize the findings from their study, "Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project," in English.Από τον American Society of Nephrology

1
Resveratrol in CKD 4:24

2y ago4:24

4:24

Dr. Diana I. Jalal and Colin Gimblet discuss the findings of their study, "Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes: A Randomized Controlled Trial," on behalf of their colleagues.Από τον American Society of Nephrology

1
Tubular Biomarkers and Kidney Histopathology in Diabetes 3:21

2y ago3:21

3:21

Dr. Christine Limonte summarizes the main findings from her study "Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes," on behalf of her colleagues.Από τον American Society of Nephrology

1
Metabolomics and Neurocognition 3:34

2y ago3:34

3:34

Dr. Arthur M. Lee provides an overview of the results of his study, "Circulating Metabolomic Associations with Neurocognitive Outcomes in Pediatric CKD," on behalf of his colleagues.Από τον American Society of Nephrology

1
Nurse Practitioner Care in CKD 4:38

2y ago4:38

4:38

Dr. Matthew James, Ellen Novak, and Tayler Scory summarize the results of their study, "Nurse Practitioner Care Compared to Primary Care or Nephrologist Care in Early CKD," on behalf of their colleagues.Από τον American Society of Nephrology

1
Interstitial Eosinophilic Aggregates Predict Kidney Failure 4:08

2y ago4:08

4:08

Dr. Hattori Koki discusses the results of his study, "Interstitial Eosinophilic Aggregates and Kidney Outcome in Patients with CKD," on behalf of his colleagues.Από τον American Society of Nephrology

1
Cardiovascular Prevention in CKD 4:46

2y ago4:46

4:46

Dr. Reza Malekzadeh gives an overview of the results of his article "Fixed-Dose Combination Therapy for Prevention of Cardiovascular Diseases in CKD: An Individual Participant Data Meta-Analysis," on behalf of his colleagues.Από τον American Society of Nephrology

1
C3G Ig-MPGN and Complement Rare Variants 7:26

2y ago7:26

7:26

Drs. Marie-Sophie Meuleman and Sophie Chauvet provide a summary of their study, "Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative Glomerulonephritis," on behalf of their colleagues.Από τον American Society of Nephrology

1
An Interview with Tristan de Nattes, the Second-Place Winner of the 2023 CJASN Trainee of the Year Competition 5:48

2y ago5:48

5:48

CJASN Editor-in-Chief Rajnish Mehrotra interviews Tristan de Nattes, the 2023 CJASN Trainee of the Year second-place winner, on his article, "A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies."Από τον American Society of Nephrology

1
An Interview with Rosa D. Wouda, the First-Place Winner of the 2023 CJASN Trainee of the Year Competition 6:02

2y ago6:02

6:02

CJASN Editor-in-Chief Rajnish Mehrotra interviews 2023 CJASN Trainee of the Year winner Rosa D. Wouda on her article, "Kaliuresis and Intracellular Uptake of Potassium with Potassium Citrate and Potassium Chloride Supplements."Από τον American Society of Nephrology

1
PLA2R Antibodies and Treatment Response 4:43

2y ago4:43

4:43

Drs. Daniel Cattran and Sean Barbour summarize the main results of their study, "Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy," on behalf of their colleagues.Από τον American Society of Nephrology

1
HPA Axis Suppression in Nephrotic Syndrome 3:24

2y ago3:24

3:24

Dr. Rajiv Sinha discusses the findings from his study, "HPA Axis in Single- versus Divided-Dose Prednisolone for First Episode Nephrotic Syndrome: An Open Label RCT," on behalf of his colleagues.Από τον American Society of Nephrology

1
Dasatinib Nephrotoxicity and Pharmacokinetics 4:07

2y ago4:07

4:07

Drs. Benjamin Adegbite and Evren Azeloglu discuss the results of their study, "Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity," on behalf of their colleagues.Από τον American Society of Nephrology

1
eGFRcys and eGFRcr Discrepancy 5:33

2y ago5:33

5:33

Dr. Morgan Grams provides an overview of the findings of her study, "Discrepancies between Cystatin C–Based and Creatinine-Based Estimated Glomerular Filtration Rates," on behalf of her colleagues.Από τον American Society of Nephrology

1
COVID-19–Associated AKI 5:19

2+ y ago5:19

5:19

Dr. Farrukh M. Koraishy summarizes the results of his study, "Geographic and Temporal Trends in COVID-Associated Acute Kidney Injury in the National COVID Cohort Collaborative," on behalf of his colleagues.Από τον American Society of Nephrology

1
Timing KRT in Children and Young Adults 3:13

2+ y ago3:13

3:13

Dr. Nick Larkins discusses the findings of his study, "Timing of Kidney Replacement Therapy among Children and Young Adults," on behalf of his colleagues.Από τον American Society of Nephrology

1
Episode 16: Appropriate CKD Referral to Specialists 16:00

2+ y ago16:00

16:00

In this episode, Dr. Peter Lin (Canadian Heart Research Centre, Canada) and Ikechi Okpechi (University of Alberta, Canada) discuss the right time to refer patients with CKD to a nephrologist. This episode also addresses rapid CKD progression and the utility of risk prediction equations. This episode is supported by an independent educational grant …

1
Episode 15: Applying CKD Interventions 15:00

2+ y ago15:00

15:00

Join host Dr. Peter Lin (Canadian Heart Research Centre, Canada) in conversation with Dr. Joel Topf (Oakland University, William Beaumont School of Medicine, USA) as they discuss how to combat CKD progression and the role of non-pharmacological vs pharmacological interventions. This episode will explore whether foundational therapies are underused …

1
Episode 14: CKD Evaluation & Measurement 16:00

2+ y ago16:00

16:00

In this episode, Dr. Peter Lin (Canadian Heart Research Centre, Canada) and Dr. Magdalena Madero (National Heart Institute Mexico City, Mexico) discuss best practices for CKD evaluation and measurement. This episode focuses on the importance of assessing GFR and albuminuria, identifying the causes of CKD, CKD progression, and when more accurate GFR…

Podcasts που αξίζει να ακούσετε

Nephrology Podcasts

Podcasts που αξίζει να ακούσετε

Οδηγός γρήγορης αναφοράς